✦ LIBER ✦

THE PROTEASOME AND PROTEASOME INHIBITORS IN CANCER THERAPY

✍ Scribed by Voorhees, Peter M.; Orlowski, Robert Z.

Book ID: 120002362
Publisher: Annual Reviews
Year: 2006
Tongue: English
Weight: 317 KB
Volume: 46
Category: Article
ISSN: 0362-1642
DOI: 10.1146/annurev.pharmtox.46.120604.141300

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Proteasome inhibitors in cancer therapy

✍ Lisa J. Crawford; Brian Walker; Alexandra E. Irvine 📂 Article 📅 2011 🏛 Springer Netherlands 🌐 English ⚖ 317 KB

Proteasome inhibitors for cancer therapy

✍ Mohamed Iqbal; Patricia A. Messina McLaughlin; Derek Dunn; Satish Mallya; Jean H 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 603 KB

239 The proteasome and proteasome pathwa

239 The proteasome and proteasome pathway inhibitors in cancer

✍ A.J. Rivett 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 128 KB

The potential of proteasome inhibitors i

The potential of proteasome inhibitors in cancer therapy

✍ Sterz, Jan; Metzler, Ivana von; Hahne, Jens-Claus; Lamottke, Britta; Rademacher, 📂 Article 📅 2008 🏛 Informa plc 🌐 English ⚖ 235 KB

Proteasome inhibitors in cancer therapy:

Proteasome inhibitors in cancer therapy: death by indigestion

✍ Rossi, M; Oberst, A; Sayan, A Emre; Salomoni, P 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 66 KB

The ubiquitin-proteasome pathway and pro

The ubiquitin-proteasome pathway and proteasome inhibitors

✍ Jayhyuk Myung; Kyung Bo Kim; Craig M. Crews 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 513 KB

## Abstract The ubiquitin‐proteasome pathway has emerged as a central player in the regulation of several diverse cellular processes. Here, we describe the important components of this complex biochemical machinery as well as several important cellular substrates targeted by this pathway and exampl